Karla L. Valenzuela-Ramirez
Seguro Social, MEX, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Circulating angiogenic factors are associated with progression to preeclampsia and the occurrence of adverse outcomes in women with gestational hypertension.
Journal: Journal of hypertension
Published: November 05, 2020
Interleukin-6 in Amniotic Fluid: A Reliable Marker for Adverse Outcomes in Women in Preterm Labor and Intact Membranes.
Journal: Fetal diagnosis and therapy
Published: August 16, 2020
Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 27, 2019
Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay.
Journal: Medicine
Published: October 04, 2018
Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes.
Journal: Medicine
Published: January 26, 2017
Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Journal: The Journal of rheumatology
Published: March 18, 2015
Frequency of Macroprolactinemia in Hyperprolactinemic Women Presenting with Menstrual Irregularities, Galactorrhea, and/or Infertility: Etiology and Clinical Manifestations.
Journal: International journal of endocrinology
Published: May 01, 2013
Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: March 06, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026